Advanced Glycation End Products in Disease Development and Potential Interventions
Antioxidants · 18.04.2025 · 14 (4) · 492
DOI: 10.3390/antiox14040492 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 18.04.2025. Verfasst von Yihan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology and Biological Engineering, South China University of Technology, Guangzhou Higher Education Mega Center, Panyu District, Guangzhou…. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 366 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advanced glycation end products (AGEs) are a group of compounds formed through non-enzymatic reactions between reducing sugars and proteins, lipids, or nucleic acids. AGEs can be generated in the body or introduced through dietary sources and smoking. Recent clinical and animal studies have highlighted the significant role of AGEs in various health conditions. These compounds accumulate in nearly all mammalian tissues and are associated with a range of diseases, including diabetes and its complications, cardiovascular disease, and neurodegeneration. This review summarizes the major diseases linked to AGE accumulation, presenting both clinical and experimental evidence. The pathologies induced by AGEs share common mechanisms across different organs, primarily involving oxidative stress, chronic inflammation, and direct protein cross-linking. Interventions targeting AGE-related diseases focus on inhibiting AGE formation using synthetic or natural antioxidants, as well as reducing dietary AGE intake through lifestyle modifications. AGEs are recognized as significant risk factors that impact health and accelerate aging, particularly in individuals with hyperglycemia. Monitoring AGE level and implementing nutritional interventions can help maintain overall health and reduce the risk of AGE-related complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou Higher Education Mega Center, Panyu District, Guangzhou 510006, China.
- BYHEALTH Institute of Nutrition & Health, No. 916, Huangpu Avenue East, Huangpu District, Guangzhou 510799, China.
Zitieren
APA
Zhang, Y., Zhang, Z., Tu, C., Chen, X., & He, R. (2025). Advanced Glycation End Products in Disease Development and Potential Interventions. Antioxidants, 14(4), 492. https://doi.org/10.3390/antiox14040492
Vancouver
Zhang Y, Zhang Z, Tu C, Chen X, He R. Advanced Glycation End Products in Disease Development and Potential Interventions. Antioxidants. 2025;14(4):492. doi:10.3390/antiox14040492
BibTeX
@article{Zhang2025,
author = {Zhang, Yihan and Zhang, Zhen and Tu, Chuyue and Chen, Xu and He, Ruikun},
title = {Advanced Glycation End Products in Disease Development and Potential Interventions},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {4},
pages = {492},
doi = {10.3390/antiox14040492}
}
EUVIMED